Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Stem Cell Therapy for Multiple Sclerosis Publisher



Rahim F1 ; Arjmand B2 ; Tirdad R3 ; Saki Malehi A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Thalassemia and Hemoglobinopathy Research Center, Golestan Avenue, Ahvaz, Khuzestan, 61537-15794, Iran
  2. 2. Imam Khomeini Hospital, Tehran University of Medical Sciences, Brain and Spinal Cord Injury Research Center, Keshavarz Bulvar, Tehran, Iran
  3. 3. Ahvaz Jundishapur University of Medical Sciences, Department of Molecular Medicine and Molecular Epidemiology, Golestan, Ahvaz, Khuzestan, 61537-15794, Iran
  4. 4. Ahvaz Jundishapur University of Medical Sciences, Department of Biostatistics and Epidemiology, School of Public Health, Golestan, Ahvaz, Khuzestan, 61537-15794, Iran

Source: Cochrane Database of Systematic Reviews Published:2018


Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and the harms of stem cell therapy for reducing the activity and severity of the disease in people with multiple sclerosis. © 2018 The Cochrane Collaboration.
Other Related Docs
43. Fluoxetine for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)